Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0369820060360030201
Jorunal of Korean Pharmaceutical Sciences
2006 Volume.36 No. 3 p.201 ~ p.207
Bioequivalence of Tylicol ER Tablet to Tylenol(R) ER Tablet (Acetaminophen 650 §·)
°­Çö¾Æ/Kang HA
±èµ¿È£/¹Ú¼±¾Ö/À±È­/±è°æ¶õ/¹ÚÀºÀÚ/Á¶Çý¿µ/À̿뺹/Kim DH/Park SA/Yun H/Kim KR/Park EJ/Cho HY/Lee YB
Abstract
Acetaminophen (paracetamol), a para-aminophenol derivative, has analgesic and antipyretic properties and weak anti-inflammatory activity. The purpose of the present study was to evaluate the bioequivalence of two acetaminophen tablets, $Tylenol^{\circledR}$ ¼ö½Ä À̹ÌÁö ER (Janssen Korea Ltd.) and Tylicol ER (Hana Pharmaceutical Co., Ltd.), according to the guidelines of the Korea Food and Drug Administration (KFDA). The release of acetaminophen from the two acetaminophen formulations in vitro was tested using KP VIll Apparatus II method with pH 1.2 buffer solution. Twenty six healthy male subjects, $22.8{\pm}1.99$ ¼ö½Ä À̹ÌÁö years in age and $65.6{\pm}8.03$ ¼ö½Ä À̹ÌÁö kg in body weight, were divided into two groups and a randomized $2{\times}2$ ¼ö½Ä À̹ÌÁö cross-over study was employed. After a single tablet containing 650 mg as acetaminophen was orally administered, blood samples were taken at predetermined time intervals and the concentrations of acetaminophen in serum were determined using HPLC with UV detector. The dissolution profiles of two formulations were similar in pH 1.2 buffer solution. The pharmacokinetic parameters such as $AUC_t$ ¼ö½Ä À̹ÌÁö, $C_{max}$ ¼ö½Ä À̹ÌÁö and $T_{max}$ ¼ö½Ä À̹ÌÁö were calculated and ANOVA test was utilized for the statistical analysis of the parameters using logarithmically transformed $AUC_t$ ¼ö½Ä À̹ÌÁö, $C_{max}$ ¼ö½Ä À̹ÌÁö and untransformed $T_{max}$ ¼ö½Ä À̹ÌÁö. The results showed that the differences between two formulations based on the reference drug, $Tylenol^{\circledR}$ ¼ö½Ä À̹ÌÁö ER, were 2.84, 1.89 and -1.36% for $AUC_t$ ¼ö½Ä À̹ÌÁö, $C_{max}$ ¼ö½Ä À̹ÌÁö and $T_{max}$ ¼ö½Ä À̹ÌÁö, respectively. There were no sequence effects between two formulations in these parameters. The 90% confidence intervals using logarithmically transformed data were within the acceptance range of log 0.8 to log 1.25 (e.g., log $0.987{\sim}log$ ¼ö½Ä À̹ÌÁö 1.08 and log $0.944{\sim}log$ ¼ö½Ä À̹ÌÁö 1.17 for $AUC_t$ ¼ö½Ä À̹ÌÁö and $C_{max}$ ¼ö½Ä À̹ÌÁö, respectively). Thus, the criteria of the KFDA bioequivalence guideline were satisfied, indicating Tylicol ER tablet was bioequivalent to $Tylenol^{\circledR}$ ¼ö½Ä À̹ÌÁö ER tablet.
KEYWORD
Acetaminophen, Tylenol ER, Tylicol ER, Bioequivalence, HPLC
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)